🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

62,31 USD

Máx. histórico

108,06

1030 días

Split 1:6 del 25/06/2013

Caída desde máximo

-42,34%

Rango 52 semanas

58,05 – 88,31

Variación hoy

+0,45%

Cierre anterior

62,03

Rango de hoy

62,05 – 64,37

Volumen hoy

1.699.286

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,37%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 20 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/11/2023 35,78 36,28 33,60 34,43 -5,20% 7,49% 1.456.800
03/11/2023 35,45 36,78 35,01 36,32 +4,85% 4,99% 2.030.600
02/11/2023 35,94 36,28 34,58 34,64 -1,31% 4,73% 1.785.200
01/11/2023 34,93 35,24 34,21 35,10 +0,69% 2,95% 1.942.700
31/10/2023 31,64 36,53 31,46 34,86 +8,63% 16,02% 3.914.300
30/10/2023 31,82 32,65 31,50 32,09 +1,10% 3,61% 2.040.800
27/10/2023 32,10 32,52 30,37 31,74 -2,07% 6,70% 2.375.600
26/10/2023 33,03 33,35 32,27 32,41 -0,55% 3,27% 756.000
25/10/2023 31,44 33,01 31,08 32,59 +2,29% 6,14% 1.586.300
24/10/2023 32,47 33,10 31,58 31,86 -0,06% 4,68% 1.026.300
23/10/2023 32,89 33,39 31,88 31,88 -3,71% 4,59% 788.900
20/10/2023 33,33 34,07 32,93 33,11 +0,91% 3,42% 1.337.100
19/10/2023 34,43 34,43 32,49 32,81 -4,34% 5,63% 1.943.600
18/10/2023 35,18 35,65 33,99 34,30 -3,05% 4,72% 1.600.800
17/10/2023 34,44 36,16 34,44 35,38 +2,11% 4,99% 1.712.900
16/10/2023 34,06 35,70 32,99 34,65 +1,29% 7,96% 1.749.900
13/10/2023 33,42 35,33 32,79 34,21 +2,46% 7,60% 1.555.500
12/10/2023 35,89 35,89 32,49 33,39 -7,12% 9,47% 1.915.500
11/10/2023 35,14 36,00 34,26 35,95 +3,10% 4,95% 3.245.800
10/10/2023 31,79 35,05 31,63 34,87 +10,00% 10,76% 4.580.700
09/10/2023 30,85 31,77 30,10 31,70 +3,59% 5,41% 1.505.800
06/10/2023 27,34 31,36 26,83 30,60 +11,39% 16,57% 2.580.700
05/10/2023 26,95 27,70 26,55 27,47 +1,55% 4,27% 939.900
04/10/2023 26,85 27,33 25,98 27,05 +0,63% 5,03% 1.192.700
03/10/2023 27,91 28,17 26,57 26,88 -3,59% 5,73% 1.386.800
02/10/2023 29,36 29,40 27,56 27,88 -5,36% 6,27% 1.580.800
29/09/2023 31,01 31,09 29,25 29,46 -4,35% 5,93% 1.689.200
28/09/2023 29,81 31,72 28,96 30,80 +2,94% 9,26% 1.627.700
27/09/2023 30,01 30,55 29,71 29,92 -0,27% 2,80% 706.400
26/09/2023 30,08 30,66 29,79 30,00 +0,07% 2,89% 1.035.900